DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry
Several Ebola viruses cause outbreaks of lethal haemorrhagic fever in humans, but developing therapies tackle only Zaire Ebola virus. Dendritic cells (DCs) are targets of this infection in vivo. Here, we found that Ebola virus entry into activated DCs requires the sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169), which recognizes sialylated gangliosides anchored to viral membranes. Blockage of the Siglec-1 receptor by anti-Siglec-1 monoclonal antibodies halted Ebola viral uptake and cytoplasmic entry, offering cross-protection against other ganglioside-containing viruses such as human immunodeficiency virus type 1., J.M.-P. and N.I.-U. are supported by the Spanish Secretariat of State of Research, Development and Innovation through grant No. SAF2016-80033-R. J.M.-P. is supported by the Spanish AIDS network Red Temática Cooperativa de Investigación en SIDA. D.P.-Z. is supported by the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund under agreement No. BES-2014-069931. J.C. is supported by Catalan Department of Health, PERIS fellowship (No. SLT006/17/00214). S.B. is supported by the Rio Hortega programme funded by the Spanish Health Institute CarlosIII (No. CM17/00242). X.M.-T. is supported by the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund under agreement No. BES-2017-082900. This research was sponsored in part by Grifols.